Information Library

Results for: Connect with investigators, regulators and physicians - Late Phase

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Oncology Experience

    Brochure — February 7, 2012
    Quintiles acquires Outcome to offer full spectrum of inventional and observational research. Together, we offer the expertise and experience in real-world and late phase research

  • Quintiles Names New Global Head of Clinical & Data Operations

    Press Release — October 6, 2011 – Quintiles announced that Steven Skolsky has been appointed Global Head of its Clinical & Data Operations (CDO) unit.

  • KoNECT & Quintiles Partner to Advance Clinical Research

    Press Release — May 30, 2011 – The Korea National Enterprise for Clinical Trials (KoNECT) and Quintiles have partnered to produce educational events in South Korea for investigators and biopharmaceutical companies.

  • The Use of Large Simple Trials

    Presentation — February 25, 2011
    Quintiles presentation at CBI Late Phase Conference explores the design and application of Large Simple Trials as a cost effective approach to delivering high quality observational research data.

  • Clinical – Smarter Trials, Accelerated Outcomes

    Brochure — February 16, 2011
    Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues.

  • Oversight Group Management Services - Aligned Action

    Brochure — February 2, 2011
    From data monitoring committees and endpoint adjudication to core laboratory oversight, Quintiles provides a one-stop solution for managing oversight groups.

  • Targeting Oncology

    Brochure — June 2, 2010
    Learn more about Quintiles leadership in oncology product development and commercialization.

  • New FDA Guidance on Antidiabetic Therapies

    White Paper — December 11, 2009
    Understanding the FDA Guidance on Assessing Cardiovascular Risks for new Antidiabetic Therapies. Learn what FDA cardiac safety requirements may mean for your development program.

  • Incremental Cost of Otitis Media Among Children in the United States

    Presentation — June 25, 2009
    Using a nationally representative data source, the study estimates the medical cost of treating otitis media among children in the US. The costs are estimated at $2 billion in 2005.

  • Patient Registries: A Taxonomy for the Design, Development and Implementation

    Presentation — June 25, 2009
    Recommendations from the ISPOR Patient Registry Classification, Strategy & Design Working Group, Team 2, for developing standard language for the characterization, classification, strategy, design, and execution of patient registries to generate data for outcomes research purposes.

Page 1 of 2 (16 results)

Subscribe to Email Based on Your Interests

Set preferences